Dr. Jordan RoseFigura from Swift Biosciences will present on the technology created to enable this research that covers 99.7 % of the SARS-CoV-2 genome from limited viral titers. Including an overview ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results